| # | Drug | Count |
|---|---|---|
| 0 | METHYLPREDNISOLONE | 151 |
| 1 | LEVETIRACETAM | 140 |
| 2 | RITUXIMAB | 122 |
| 3 | LEVETIRACETAM IN SODIUM CHLORIDE | 119 |
| 4 | LEVETIRACETAM INJECTION | 119 |
| 5 | LEVETIRACETAM ORAL | 119 |
| 6 | NIVOLUMAB | 118 |
| 7 | PREDNISONE | 100 |
| 8 | MYCOPHENOLATE MOFETIL | 99 |
| 9 | ADALIMUMAB | 97 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | XENON | 1 | 0.0769 |
| 1 | ALITRETINOIN | 1 | 0.0084 |
| 2 | CEFPROZIL | 5 | 0.0064 |
| 3 | SARECYCLINE HYDROCHLORIDE | 1 | 0.0050 |
| 4 | LIDOCAINE, PRILOCAINE | 1 | 0.0050 |
| 5 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 6 | L DOPA | 1 | 0.0037 |
| 7 | LOTEPREDNOL ETABONATE AND TOBRAMYCIN | 1 | 0.0025 |
| 8 | SENNOSIDES A AND B | 4 | 0.0024 |
| 9 | OCTOCRYLENE, AVOBENZONE | 1 | 0.0022 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 316 |
| 1 | Corticosteroid [EPC] | 301 |
| 2 | Benzodiazepine [EPC] | 159 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 152 |
| 4 | Atypical Antipsychotic [EPC] | 134 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 117 |
| 6 | Platinum-based Drug [EPC] | 107 |
| 7 | Anti-epileptic Agent [EPC] | 93 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 74 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 63 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Inhalation Diagnostic Agent [EPC] | 1 | 0.0769 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 316 | 0.0032 |
| 2 | Human Immunoglobulin G [EPC] | 53 | 0.0025 |
| 3 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 3 | 0.0024 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 14 | 0.0024 |
| 5 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 6 | Typical Antipsychotic [EPC] | 46 | 0.0018 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 34 | 0.0016 |
| 8 | Somatostatin Analog [EPC] | 10 | 0.0015 |
| 9 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |